Glenmark Pharmaceuticals Inc., USA to launch Potassium Phosphates Injections

Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch1 of Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5 mL and 45 mmol P / 66 mEq K per 15 mL Single-Dose Vials and 150 mmol P / 220 mEq K per 50 mL Pharmacy Bulk Package Vials. Glenmark's Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5 mL and 45 mmol P / 66 mEq K per 15 mL Single-Dose Vials and 150 mmol P / 220 mEq K per 50 mL Pharmacy Bulk Package Vials is bioequivalent and therapeutically equivalent to the reference listed drug, Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5 mL, 45 mmol P / 66 mEq K per 15 mL, and 150 mmol P / 220 mEq K per 50 mL of Fresenius Kabi [NDA 212832]. Glenmark will begin distribution in March 2026.

According to IQVIA® sales data for the 12-month period ending January 2026, the Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5 mL, 45 mmol P / 66 mEq K per 15 mL, and 150 mmol P / 220 mEq K per 50 mL market2 achieved annual sales of approximately $50.7 million*.

Commenting on the launch, Marc Kikuchi, President & Business Head, North America said, "We look forward to growing our portfolio of products within the institutional channel with the upcoming launch of Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5 mL and 45 mmol P / 66 mEq K per 15 mL Single-Dose Vials and 150 mmol P / 220 mEq K per 50 mL Pharmacy Bulk Package Vials. We continue to strengthen our commitment to bring quality and affordable alternatives to market for patients in need with each injectable launch."

Shares of Glenmark Pharmaceuticals Limited was last trading in BSE at Rs. 2170.00 as compared to the previous close of Rs. 2258.00. The total number of shares traded during the day was 29687 in over 5623 trades.

The stock hit an intraday high of Rs. 2265.00 and intraday low of 2162.80. The net turnover during the day was Rs. 64877713.00.

Source : Equity Bulls

Keywords

GlenmarkPharmaceuticals INE935A01035 PotassiumPhosphates Injections